Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Kidney Machine Perfusion
NCT01731457Phase 2Completed
- Sponsor
- Medical University of Warsaw
- Start
- Apr 2011
- Primary completion
- Feb 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised trial of etanercept in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Medical University of Warsaw. Primary endpoints: Delayed Graft Function at 1 week and Graft Survival at 12 months. Started Apr 2011; status: completed.
02
Drugs
etanercept
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01731457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01731457.